Traub Capital Management »

Biogen Idec shares owned by Traub Capital Management

Quarter-by-quarter ownership of Biogen Idec (BIIB) shares owned by Traub Capital Management from 13F filings

Historical chart of Traub Capital Management investment in Biogen Idec

Tip: Access up to 7 years of quarterly data

All positions including Biogen Idec held by Traub Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biogen Idec by Traub Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $268k 1.9k 140.08
2025-06-30 $240k 1.9k 125.59

More positions owned by Traub Capital Management

Apple (AAPL)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
Janus Detroit Str Tr Hendrson Aaa Cl (JAAA)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Schwab Strategic Tr Fundamental Us S (FNDA)
Meta Platforms Cl A (META)
Ishares Tr 1 3 Yr Treas Bd (SHY)
Spdr Series Trust Bloomberg 3-12 M (BILS)
Ishares Tr 0-5 Yr Tips Etf (STIP)
Global X Fds Us Pfd Etf (PFFD)
Schwab Strategic Tr Fundamental Intl (FNDF)
Amazon (AMZN)
Vanguard Whitehall Fds Em Mk Gov Bd Etf (VWOB)
Ishares Tr Core S&p Us Vlu (IUSV)

View all positions for Traub Capital Management

Top funds holding Biogen Idec

Vanguard Group
PRIMECAP Management Company
BlackRock
State Street Corporation
Point72 Asset Management
Wellington Management Company
Geode Capital Management
Invesco
Susquehanna International
Morgan Stanley
AQR Capital Management
Legal & General Group
Northern Trust
Millennium Management
Pacer Advisors

View all funds holding Biogen Idec